| Application no. and date | 15836431.5 (espacenet) (Federated) (European Patent Register), 20150824 | | Patent/reg. no. and date | DK/EP 3185867, 20210113 | | Publication date | 20170705 | | Priority no. and date | US 201462041341 P, 20140825 | | EP pub. no. and date |
EP 3185867 20170705 | | Effective date | | | Applicant/owner | Alkermes Pharma Ireland Limited, Connaught House
1 Burlington Road
Dublin 4, IE | | Applicant ref. no. | P25475DKEP | | Inventor | WRIGHT, Steven G., 7012 Juniperview Lane
Madeira, Ohio 45243, US,
MORALES, Wilfredo Jr., 829 Oak Forest Drive
Morrow, OH 45152, US,
ZEIDAN, Tarek A., 499 Lowell Street
Lexington, Massachusetts 02420, US,
CHIARELLA, Renato A., 55 Magazine Street, Apt. 41
Cambridge, Massachusetts 02139, US,
PERRY, Jason M., 125 Rindge Avenue, Apt 1
Cambridge, Massachusetts 02140, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , C07D 401/12 (2006.01) | | Title | KRYSTALLISERINGSFREMGANGSMÅDE AF ARIPIPRAZOLDERIVATER I FORLÆNGEDE FRIGIVELSESFORMULERINGER TIL BEHANDLING AF SKIZOFRENI | | Int. application no. | US2015046525 | | Int. publication no. | WO2016032950 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
